(MENAFN- GetNews)


"Dr. Tommy Rhee"RheeGen®, a pioneering leader in cell-free topical regenerative therapy, announced today a strategic partnership with Winback, a global innovator in TECAR energy and electrotherapy technologies.

Tampa, FL - Nov 10, 2025 - RheeGen®, a pioneering leader in cell-free topical regenerative therapy, announced today a strategic partnership with Winback, a global innovator in TECAR energy and electrotherapy technologies. The collaboration aims to integrate the regenerative power of RheeGen's topical bio-signal technology with Winback's advanced high-frequency energy systems-offering a new era of non-invasive recovery and performance enhancement for clinicians, athletes, and patients worldwide.

RheeGen®, developed by Dr. Tommy Rhee, CEO and Founder of Physical Chiropractic of Tampa Bay, and the leading expert in topical stem cell therapy, has revolutionized the field of regenerative medicine with its proprietary transdermal delivery system. By harnessing bioactive molecules inspired by stem cell science, RheeGen® delivers targeted cellular communication and recovery without injections or invasive procedures.

Winback, led in the Americas by Matthieu Commeau, Managing Director at Winback Group, has become a global reference in TECAR therapy-using high-frequency electrical currents to accelerate tissue healing, reduce inflammation, and enhance natural biological recovery.

Through this collaboration, clinicians will be able to combine RheeGen®'s bio-regenerative topical formulations with Winback's cutting-edge TECAR systems, creating a synergistic effect that promotes deeper cellular activation, improved microcirculation, and faster recovery outcomes.

“This partnership bridges two complementary innovations-RheeGen's cell-free regenerative science and Winback's energy-based technology,” said Dr. Tommy Rhee, CEO and Developer of RheeGen.“Together, we're advancing non-invasive regenerative medicine and empowering practitioners with a powerful, science-backed solution for pain relief, performance, and repair.”

“We're excited to collaborate with Dr. Rhee and the RheeGen® team,” said Matthieu Commeau, Managing Director of Americas at Winback Group.“Our shared curiosity lies in how regenerative topical formulations may complement Winback TECAR Therapy in promoting better mobility and comfort for patients.” Our teams will continue exploring educational and clinical opportunities where both innovations can naturally intersect in musculoskeletal and sports-therapy settings.

For more information, visit:

MENAFN10112025003238003268ID1110323723